The BioCalendar

The World Orphan Drug Congress
2024-04-23 - 2024-04-25 | PA
The World Orphan Drug Congress brings together leading pharmaceutical and biotech companies, government and regulatory authorities, patient advocacy groups, payers, investors and solution providers. The conference is a place to meet and brainstorm ways to advance orphan drug development and improve access to life-saving therapies.
Join us for three days in Boston for the most comprehensive program and inclusive gathering of rare disease stakeholders.

2024 State of Possible Conference
2024-04-24 | PA
MassBio’s State of Possible Conference is the premier event for the Massachusetts life sciences industry.
Attendees from the lab to the c-suite will experience a packed, ‘can’t miss’ agenda featuring top pharmaceutical and biotech leaders taking the stage to speak to the conference theme of Meeting the Moment. Experience engaging panel discussions on surviving biotech’s choppy waters and rewriting what is possible in science, with ample time for networking, partnering, and celebrating. New this year – we will recognize MassBio members during an award showcase, including the Henri A. Termeer Innovative Leadership Award, and host a surprise experience designed to “give back” to the community.
Register today to join 500+ attendees from across the ecosystem.
2024 State of Possible Conference Speakers:

Devin McCourty, 3x Super Bowl champion and sickle cell disease advocate
Governor Maura Healey, Commonwealth of Massachusetts
John F. Crowley, President & CEO, Biotechnology Innovation Organization (BIO)
Reshma Kewalramani, President & CEO, Vertex Pharmaceuticals
Peter Kolchinsky, Managing Partner, RA Capital Management
Tess Cameron, Principal, RA Capital Management
Susan Windham-Bannister, President & CEO, Biomedical Growth Strategies
Kendalle Burlin O’Connell, CEO & President, MassBio
Panel discussions

Success in Choppy Waters

Doug Banks, Executive Editor, Boston Business Journal – Moderator
Sharon Cunningham, CEO & Co-Founder, Shorla Oncology
Barry Greene, CEO, Sage Therapeutics
Mike Nally, CEO, Generate Biomedicines
Daphne Zohar, Founder and CEO, PureTech Health

Rewriting What is Possible

Chris Garabedian, Chairman and CEO, Xontogeny – Moderator
Abe Ceesay, CEO, Rapport Therapeutics
Emma Lees, Ph.D, Sr. Vice President of Research and Early Development, Bristol Myers Squibb
Jacob Sten Petersen, Senior Vice President, Head of Global Nucleic Acid Therapies, Novo Nordisk
Stan Wang, MD, Ph.D, CEO & Founder, Thymmune Therapeutics

Mid-Atlantic Life Sciences & Biotech Summit
2024-04-24 08:00 - 12:00 UTC | PA
WHAT YOU’LL LEARN AT THIS COMMERCIAL REAL ESTATE LIFE SCIENCES CONFERENCE

What continues to drive the investment appetite for the life sciences sector within the Mid-Atlantic region?
Between construction costs and rising interest rates, how has the impact of the last few months affected current projects? What strategies are being implemented to navigate through these challenges in 2024?
How are resilience and risk mitigation strategies being integrated into the design and development of commercial real estate for life sciences in the Mid-Atlantic?
Who is currently putting money into life sciences and biotech facilities in DC/MD/VA and beyond? What types of deals are moving forward? What are investors and brokers seeing in terms of leasing activity?
What are current tenant demands? What types of innovations, designs and amenities are being implemented in facilities?
How are Mid-Atlantic life sciences companies adapting their talent retention strategies in the face of increasing competition in the industry?
Are there certain locations that are seeing more attraction? How does this compare to the past few years?
What types of economic drivers are incentivizing top companies to locate to the Mid-Atlantic?
What role does collaboration and partnerships play in the development of commercial real estate projects within the Mid-Atlantic life sciences ecosystem?

2024 Align Summit
2024-04-25 | PA
This year’s Align Summit, a partnering event for funders and early-stage companies, will focus on artificial intelligence and machine learning in drug discovery and development with insights from our partners Locust Walk and McKinsey & Company. We will explore this topic through four panel discussions from the perspective of biotech or AI/ML. The Align Summit will include 50 presentations of two curated tracks — seed to Series A biotech companies and emerging companies focused on AI/ML R&D — along with all day partnering opportunities through our powerful mobile app.

Big4Bio CFO Reception
2024-04-25 07:30 - 09:00 UTC | PA
Jami Rubin of Boundless Bio and Peter Slover from Contineum Therapeutics
will be sharing their stories of how they completed their recent IPO’s
Brought to you by C3, Latham & Watkins, DFIN, and Big4Bio

Thursday, April 25, 2024
7:30-9:00am
Latham & Watkins Office
12670 High Bluff Drive
San Diego, CA 92130

New York Life Sciences & Biotech
2024-04-25 10:30 - 15:30 UTC | PA
What You’ll Learn:

How is the capital markets slowdown and rising interest rates impacting the current growth of the biotech sector?
Understand where New York ranks nationally with life sciences developments and what the future hold for this market.
Which life sciences developments are best in class in New York and what is driving tenants to these buildings?
Learn which infrastructure policies are driving development activity, project approval and fostering growth for the region’s tenants.
With the leasing slowdown, how is this impacting supply and demand dynamics and how owners feel about building on spec?
Which design elements are in highest demand for driving leasing activity and how does this differ in New York City vs. the NY suburbs?
Which markets can serve as a blueprints or reference points for the future of the city’s life science developments?

How you’ll do more business: Enhance your business by understanding how the New York life sciences community is growing to compete with other top biotech hubs across the country. Gain a better understanding for what tenants are looking for as they grow and expand. Additionally, what design and development strategies are top executives implementing in these top clusters.
Who attends: Investors, owners, developers, lenders, biotech tenants, brokers, public sector companies, architects, contractors, engineers and property managers.
Why should you attend: Bisnow events bring together the biggest power players in the industry to identify opportunities, build your network, and expand your business. With the largest audience of commercial real estate professionals in the world, no one knows how to help your business more than us.
For questions, recommendations, comments, or press inquiries please email our Director of New York Events, Chris Picher at chris.picher@bisnow.com.
To request disability-related accommodations, please contact ellie.meyer@bisnow.com no later than seven business days prior to the event.

Tomorrow’s Trailblazers in Science
2024-04-25 13:00 - 14:00 UTC | Online webinar, United States
Each year, STAT chooses a new class of Wunderkinds, showcasing stars of science and medicine who are in the midst of launching their careers. Join for a conversation with past all-star Wunderkinds to see where they are now, how their journeys have unfolded, and hear their most inspiring and innovative ideas.

Deloitte Life Sciences Industry Accounting Guide Launch & Networking Party
2024-04-25 15:30 - 18:30 UTC | Seattle, Seattle, WA, United States
Join us for a life sciences industry networking event at Latta Wines. Enjoy the exquisite wines and food, expand your network, and connect with the life sciences community as we unveil the 2024 Deloitte Life Sciences Accounting Guide.

Location:
Latta Wines

3933 1st Avenue South

Seattle, Washington 98134

Outdoor Ventura BioCenter Community Life Science Event in Thousand Oaks
2024-04-25 16:30 - 18:30 (America/Los_Angeles) | PA
We are very excited to announce our outdoor Ventura BioCenter Life Science Community Event in Thousand Oaks.
Please join your colleagues from Amgen, ADRx, AGQ Labs, Arcutis Biotherapeutics, Atara Biotherapeutics, Cal State Channel Islands, Capsida Biotherapeutics, Curia Global, Hygiena, LungLife AI, PBS Biotech, Takeda, and all of the companies in the Ventura BioCenter, along with many suppliers for a great event and get together.
The event will be a combination of vendor exhibits, BBQ, beer & wine, and lots of networking.
FREE to life science job-related employees (including executives, purchasing, scientists, clinical, manufacturing, etc.) at life science companies and research institutes.
Product and Service providers that sell to the life science community, BVS and non-BVS suppliers, lawyers, consultants, etc. will pay a $200.00 fee to attend.
We look forward to seeing everyone there!

STAT in DC: Policy in Health Care
2024-04-29 18:00 - 21:00 UTC | PA
Access to health care is directly impacted by decisions being made by policymakers. STAT’s DC reporters will take a deep dive into how we can ensure patient care is remaining a top priority on the hill during this election year. Join us for an evening with patient advocates, policymakers, and industry leaders to discuss how policy decisions are impacting health care quality and access.

Strategies to Effectively Accelerate Your Drug Development
2024-04-30 13:00 - 17:00 UTC | Cambridge, MA, Cambridge, MA, 02139, United States
Join our panel of experts as we explore a spectrum of topics, including the latest regulatory updates and effective strategies to navigate them. We’ll discuss the impact of the current financial landscape on various biotech companies, the optimal pathway for nonclinical gene therapy development, and how ethnobridging can significantly accelerate project timelines.
This complimentary event is by invitation only and registration is mandatory by filling out the form

Boston Life Sciences Roundtable
2024-05-01 13:30 - 17:00 UTC | PA
Location

MassBio Hub
700 Technology Square
Cambridge, MA 02139
1:30 p.m. Registration | 2:00 p.m. Program
Reception to Follow

RSVP Here
For more information, contact bosevents@sidley.com.

Date
Wednesday, May 1, 2024
Sidley Lawyers
Rebecca K. Wood | James R. Johnson | Geoffrey W. Levin | Donielle McCutcheon | Asher M. Rubin | Adriana V. Tibbitts

The Global Synthetic Biology Conference
2024-05-06 - 2024-05-09 | San Jose, San Jose, CA, United States
Join us for an unparalleled four-day summit delving into synthetic biology. Explore why the costs of reading, writing, and editing DNA plummet while speed and accessibility soar. Gain insights into cutting-edge medical advancements such as cell therapies, vaccines, and living medicines. Discover how companies harness biology to produce bio-based jet fuel, textiles, concrete, and other chemicals and materials. Engage with trailblazing entrepreneurs crafting innovative foods, crops, and fragrances. Join us to see the potential applications of these technologies in shaping sustainable manufacturing ecosystems.

Fierce Medical Affairs Strategic Summit (MASS)
2024-05-06 - 2024-05-08 | PA
The Fierce Medical Affairs Strategic Summit (MASS) serves as the premier learning and networking platform for Medical Affairs, Medical Communication and Field Medical leaders. Through dynamic discussions, focused tracks, and hands-on workshops medical affairs executives can connect on current challenges & opportunities found within their role to become better equipped in developing a unified scientific voice across their organization.
Don’t miss the opportunity to gain best practices in medical affairs strategy development and ensuring scientific materials are created and shared in a regulatory-compliant manner to internal/external stakeholders and thought leaders.

SynBioBeta
2024-05-06 - 2024-05-09 | PA
The Global Synthetic Biology Conference is an innovation network that brings together individuals who share a passion for biological engineering and sustainability. We gather engineers, investors, innovators, and entrepreneurs across a broad base of industries and company sizes, who are committed to using biology to build a better world.

Women Thriving in STEM – Burnout Workshop & Networking Event in La Jolla, CA
2024-05-07 16:00 - 19:00 (America/Los_Angeles) | PA
BVS in collaboration with BioMed Realty inviting you to our “Women Thriving in Stem – Burnout Workshop & Networking Event”
Please join and support all of the powerful women in STEM coming together to unite for an incredible evening featuring an empowerment workshop given by Pamela Gardner – called “Manage Your Burnout & Get Your MoJo Back”.
The night will also include networking and light refreshments.
Agenda:
4:00 – 5:00 PM – Registration, Networking, Light Refreshments
5:00 – 6:00 PM – “Manage Your Burnout & Get Your MoJo Back” Workshop given by Pamela Gardner
6:00 – 7:00 PM – Networking, Light Refreshments
We look forward to seeing you there!

BioMed Realty and BVS’ Biotech Community Event in Cambridge
2024-05-08 16:00 - 18:30 (America/New_York) | PA
BVS in collaboration with BioMed Realty is hosting a Biotech Community Event in Cambridge.
The event will be held at 65 Franklin Street and all the tenants in the surrounding buildings, plus all the Biotech/Pharma companies in Cambridge/Boston are invited to attend.
This is a special Biotech Community Event sponsored by some of the top scientific suppliers in the industry featuring their clinical products/services, along with it being a wonderful way for scientists and science vendors to network in a relaxed evening venue.
The event will be a combination of vendor exhibits, great food, beer & wine and lots of networking.
FREE to life science job-related employees (including executives, purchasing, scientists, clinical, manufacturing, etc.) at life science companies and research institutes.
Product and Service providers that sell to the life science community, BVS and non-BVS suppliers, lawyers, consultants, etc. will pay a $200.00 fee to attend.
We are looking forward to seeing everyone.

Battle of the BioTech Bands 2024
2024-05-08 18:00 - 22:30 UTC | PA
BIO+TECH BANDS COMPETE!WEDNESDAY May 8th 20246:00 PM – 10:30 PM$60 entry TicketsROYALE NIGHTCLUB. 279 TREMONT STREET. BOSTON, MA

Bio€quity Europe
2024-05-12 - 2024-05-14 | PA
Bio€quity Europe 2024
For more than 20 years, Bio€quity Europe has been where CEOs and investors gather to network, partner, and debate critical issues facing the biotech industry.

Join BioCentury, EBD Group, and Regional Host Committee Chair Ysios Capital, May 12-14, 2024, in one of the culinary capitals of the world. Don’t wait to book your ticket to San Sebastian. Last year, Bio€quity sold out.

Biology of Cilia and Flagella
2024-05-12 - 2024-05-16 | PA
Launched in 2007, this conference is the leading international meeting covering all aspects of cilia and cilia-related diseases, providing the premier forum to share the newest research. The program will cover the ﬁeld from basic research in model organisms to the development of treatments for human ciliopathies.

PEGS Boston
2024-05-13 - 2024-05-17 | PA
PEGS Boston Summit is the Essential Industry Conference for Streamlining Biologics Development

The PEGS Boston Summit brings together leading experts at the forefront of biologics innovation, providing insights into the latest technologies, research, and advancements in drug development, protein and antibody engineering, immunotherapy, immunogenicity, expression platforms, multispecific antibodies, machine learning and AI in biologics, and more.
PEGS Boston features main conference sessions as well as deep dive training seminars and topic-focused short courses. PEGS Boston Summit is your number one resource for protein engineering updates and is the conference to attend in 2024 to network, collaborate, and learn from the industry’s best.

AAPS 2024 National Biotechnology Conference
2024-05-13 - 2024-05-16 | San Francisco, CA, San Francisco, CA, United States
Tracks and Themes
Track 1: Advances in Discovery, Formulation, and Delivery of New Modalities
A tremendous rise in the biologics market has driven significant interest in their discovery and in using novel drug delivery systems to enable drug delivery via different routes. This track focuses on aspects of the discovery and development of biologics and new modalities. Submissions are invited on topics related to multi-specific antibodies, oligonucleotides, proteins, nanobodies, genes, RNA, peptides, cell-free manufactured proteins, vaccines, cells, and allogenic and synthetic cells. Discussions are encouraged on diverse strategies for the discovery, formulation, and delivery of these modalities to address unmet medical needs.
Theme 1: Preformulation and Formulation Approaches for Biologics and New Modalities
Keywords: Preformulation, Formulation, Stability, CMC, Excipient, Impurities, Biologics
Explore the challenges associated with preformulation and formulation development of biologics and new modalities. In addition to the modalities mentioned above under Track 1, submissions related to screening and excipients selection, the impact of excipients on pharmacokinetics/pharmacodynamics (PK/PD), and stability are welcome. Discussions of Chemistry, Manufacturing, and Controls (CMC) issues related to the development of these modalities are encouraged.
Theme 2: Drug Delivery for New Modalities and Therapies
Keywords: Drug Delivery, Gene Delivery, Vaccines, Cell Therapy, Personalized Medicine
This theme focuses on different strategies and challenges involved in the design of drug delivery systems, the delivery of biologics, and manufacturing challenges in the development of novel drug delivery systems. Topics such as nanoparticles, liposomes, hydrogels, Antibody-Drug Conjugates (ADCs), nanobots and devices, personalized medicines, cell-based therapies, and viral and non-viral gene delivery are the primary focus. Submissions on advances in the delivery of genes, vaccines, and biotherapeutics via non-parenteral routes of administration (e.g., oral, topical, intravitreal, nasal, and inhalation) are encouraged.
Theme 3: AI/ML in Drug Discovery and Development
Keywords: Artificial Intelligence, Synthetic Biology, Gene Editing, CRISPR, Discovery
This track explores how Artificial Intelligence/Machine Learning (AI/ML) and big data are transforming the landscape of drug development and reducing discovery time and cost. Submissions are welcome on novel biotherapeutics developed using AI; AI-enabled gene-editing drugs; and the combination of AI, synthetic biology, and cell manufacturing as well as their impact on new drugs, novel design, and manufacturing processes. Topics to be covered include: CMC and regulatory issues; the use of AI in CMC and process development; decentralized manufacturing, risks, and benefits associated with using AI in drug discovery and development; and data integrity concerns.
Track 2: Novel Strategies to Advance Biotherapeutic Development
Advances in therapeutic development for targeted delivery, platform technology, high-content bioanalysis, and data science.
Theme 1: Development Strategy for Novel Targeted Therapeutic Delivery
Keywords: Targeted Delivery, Bioanalysis, Pharmacokinetics
As the field of targeted drug delivery advances with new modalities such as lipid nanoparticles, cell therapies, and gene therapeutics, science is also gaining ground in the design of protein therapeutics tailored to deliver to specific tissues (examples: eye, tumor, or brain) and methods for bioanalysis. Discuss how pharmacokinetics, pharmacodynamics, and immunogenicity bioanalysis and data for tissue-targeted therapeutics can inform and advance therapeutic development.
Theme 2: Advances in Analytical and Bioanalytical Platform Technology
Keywords: Instrumentation Platforms, Flow Cytometry, Multiplexing, Imaging, Data Science
The field of analytical platform technology is racing to keep pace with the emergence of new modalities such as oligonucleotides and cell and gene therapies, as well as the increasing need for more informative analytical evaluation of traditional therapeutics such as monoclonal antibodies and antibody drug conjugates. Discuss high-resolution instrumentation techniques, multiplexing, flow cytometry, imaging platforms, and other technological advancements. Submissions are also welcome related to the associated developments in data science that add increased information to biodistribution, pharmacokinetics, immunogenicity, and pharmacodynamics analyses.
Theme 3: High Content Bioanalysis
Keywords: MAPPS, In-Silico Prediction, Immunogenicity Prediction, Artificial Intelligence, Machine Learning, personalized medicine, Omics
High Content Bioanalysis in genomics, proteomics, metabolomics, and lipidomics, along with technologies to identify and measure biomarkers at the single cell level, combined with advances in data sciences (artificial intelligence) are exponentially evolving. Discuss case studies and platforms for high content bioanalysis for personalized medicine, novel -omic approaches, immunogenicity prediction, immunogenicity risk assessments, and digital biomarkers. Submissions are also welcome that explore evolving data science and artificial intelligence methodologies for analysis of large data set

Pennsylvania Biotechnology Center’s Golf Outing
2024-05-13 | New Hope, PA, PA, 18938, United States
Location: Jericho National Golf Club, New Hope, PA
Over a hundred biotech leaders and other golfers will join us at this top-tier golf course on May 13 for a day of great food, refreshments and fun.
Interested in joining us? Contact Alaina Schukraft at Alaina.Schukraft@hepb.org! For more information click here.

Biotechgate Digital Partnering
2024-05-13 - 2024-05-17 | Online webinar, United States
The BIOTECHGATE DIGITAL PARTNERING event series was started in spring 2020 due to the COVID-19 pandemic. We offer companies the possibility to conduct their business development and interact with partners, clients, licensees / licensors and suppliers in a secure, online environment. This offer is for anybody working in business development and licensing in life sciences including biotech, medtech, pharma, diagnostics, healthtech, suppliers, consulting, and not-for-profit organizations.
Participation is free of charge. As a member company of any of our Biotechgate partners, you get free premium access to Biotechgate Digital Partnering. If you are not a member of any of our partners, you can still register for free with the option to upgrade anytime.

Fierce Pharma PR & Communications Summit West
2024-05-14 - 2024-05-15 | PA
The Fierce Pharma PR & Communications Summit West is the one and only conference on the west coast dedicated to providing life science communicators with timely industry updates and best practices for successful communications strategies during today’s complex healthcare environment. We’re bringing this dynamic community together in-person to connect and create meaningful and in-depth discussions on not only the challenges, but for also collectively identifying key solutions.

BVS’ Biotech Community Event at Biovista, San Diego
2024-05-14 16:30 - 19:00 (America/Los_Angeles) | PA
We are very excited to announce our outdoor Biotech Community Event at the Biovista Life Science Campus.
We are inviting all the tenants and all local life science researchers and entrepreneurs in the surrounding area to attend.
This is a special Biotech Community Event sponsored by some of the top scientific suppliers in the industry, along with it being a wonderful way for scientists, entrepreneurs and science vendors to network in a relaxed evening venue.
The event will be a combination of vendor exhibits, drinks and appetizers provided by California English and lots of networking.
FREE to life science job-related employees (including executives, purchasing, scientists, clinical, manufacturing, etc.) at life science companies and research institutes.
Product and Service providers that sell to the life science community, BVS and non-BVS suppliers, lawyers, consultants, etc. will pay a $200.00 fee to attend.
We look forward to seeing you there!

Increasing The Stakes: Creating and Selling Your Valuation Story in Changing Times
2024-05-15 11:00 - 12:15 UTC | Online webinar, United States
Immune therapies and obesity treatments are getting lots of attention, and many pundits would tell you platform strategies and gene therapies have fallen out of favor. And while the Biotech Index has rebounded almost 50% from its October 2023 low, many companies are still struggling to fundraise. Our outstanding group of panelists will help distill myth from reality as they discuss how they convey their valuation story, and how they have drawn on their commercial launch experience to successfully raise capital through changing cycles and changing times.

US Pharma and Biotech Summit
2024-05-16 | PA
2024 is a pivotal year for US healthcare, in particular for the pharma and biotech industries. A presidential election will influence crucial policies on drug pricing and health financing for years to come. AI technologies are evolving from buzzwords to making an impact in drug R&D. Pharma is facing a huge patent cliff. And the biotech market appears to be pulling out of a slump just as the US economy executes the soft landing policymakers have hoped for.
The Financial Times US Pharma and Biotech Summit returns to New York in May 2024, partnered with Endpoints News for the first time. The event will gather biopharma leaders, regulators, investors and scientists to share unique insights about the year ahead and discuss the most important trends affecting the industry, and the country.
Join us to learn how the new market cycle will finance the next period of investing in innovation. Debate the dueling approaches to the US life expectancy crisis. Hear how artificial intelligence is splitting into two technological camps. And learn how drug makers, tech startups and insurers are fighting it out to redefine their relationship with patients.

2024 STAT Breakthrough Summit West
2024-05-16 | PA
Medicine’s future, now

To a person 20 years ago, today’s medicine would seem like science fiction: routine DNA sequencing, gene editing, and surgery that can help an 80-year-old Mick Jagger dance. So what will the next two decades bring? We’ll peer into the mists, looking at GLP-1 drugs for psychiatry, a new age of individualized gene editing, and the potential of artificial intelligence to reduce the failure rate of inventing new medicines. We’ll also check into the financial apparatus that is supposed to fund all this cool research. Join us for a series of high-level, interactive sessions – and join the conversation.
San Francisco & Virtual

The Future of Life Sciences: Can Biotech Bounce Back?
2024-05-16 08:30 - 11:00 UTC | PA
Don’t miss your chance to hear from leading Life Science and CRE experts about the state of the industry and development in Philadelphia.
Agenda:

8:30-9:15am: Breakfast & Networking
9:15-10am: Panel 1 with Reporter Paul Schwedelson
10-11am: Panel 2 with Senior Reporter John George

Panel 1: After developers rushed to build new lab space, tenant demand and new development has slowed down. What does that mean for the future of Philadelphia’s life sciences sector and how will real estate developers respond?
Moderated by Reporter Paul Schwedelson

Nelson Way, director of leasing and development, Ensemble Real Estate Investments
Anne Cummins, co-founder and chief operating office, Gattuso Development Partners
Pete Cramer, vice president and market executive, Wexford Science + Technology
Jeff DeVuono, executive vice president, life science division, Brandywine Realty Trust

Panel 2: The Cellicon Valley Scene: State of the life sciences industry
Moderated by Senior Reporter John George

William Chou, M.D., CEO of Passage Bio
Bruce Levine, Professor of gene therapy, University of Pennsylvania, co-founder of Capstan Therapeutics
Tiffany Wilson, president and CEO of the University City Science Center
Lorenzo Pellegrini, managing partner of the Hatch Biofund
Heather A. Steinman, Ph.D., MBA, Senior Vice President for Business Development and Executive Director of Technology Transfer, The Wistar Institute
